Sequential Optic Neuropathy in Idiopathic Intracranial Hypertension: A Diagnostic Challenge of Possible Superimposed Nonarteritic Anterior Ischemic Optic Neuropathy
Article Sidebar
Main Article Content
Abstract
Idiopathic intracranial hypertension (IIH) and non-arteritic anterior ischemic optic neuropathy (NAION) are distinct optic nerve disorders that may present diagnostic overlap in patients with optic disc edema and shared vascular or structural risk factors. We report a 40-year-old woman with obesity and systemic vascular comorbidities who initially presented with painless vision loss in the right eye consistent with NAION. Four months later, she developed new left optic disc edema, accompanied by headaches and pulsatile tinnitus. Neuroimaging demonstrated partial empty sella, posterior globe flattening, and bilateral transverse sinus stenosis, and lumbar puncture revealed elevated opening pressure with normal cerebrospinal fluid composition, supporting a diagnosis of IIH. Following treatment with carbonic anhydrase inhibitors, papilledema partially improved; however, a new inferior arcuate visual field defect with worsening disc edema subsequently developed in the left eye, raising concern for possible superimposed NAION. During follow-up, disc edema gradually resolved while the visual field defect persisted. This case underscores the diagnostic complexity of distinguishing possible superimposed NAION from progressive papilledema-related visual loss and highlights the importance of considering ischemic optic neuropathy when new or asymmetric visual field defects develop in patients with IIH.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the x may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.use or modification of the articles is prohibited without permission.
statements expressed in the articles are solely the opinions of the authors.
authors are fully responsible for the content and accuracy of their articles.
other reuse or republication requires permission from the journal."
References
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81(13):1159-65.
Xie JS, Donaldson L, Margolin E. Papilledema: a review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol 2022;67(4):1135-59.
Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med 2015;372(25):2428-36.
Lee R, Alryalat SA, Deyabat OA, Laylani N, Mortensen P, Lee AG. Non-arteritic anterior ischemic optic neuropathy secondary to idiopathic intracranial hypertension. Am J Ophthalmol Case Rep 2024;34:102057.
Ma J, Micieli JA. Anterior ischemic optic neuropathy in a patient with papilledema from idiopathic intracranial hypertension. Am J Ophthalmol Case Rep 2020;17:100593.
Pirouzmand N, Micieli JA. Optic disc restricted diffusion in papilledema-related anterior ischemic optic neuropathy. Can J Neurol Sci 2023;50(3):464-5.
Deb AK, Ghag G, Gera P, Kasturi N, Sarkar S. Bilateral nonarteritic anterior ischemic optic neuropathy with idiopathic intracranial hypertension secondary to attempted abortion related hemorrhage: a rare case report. Indian J Ophthalmol Case Rep 2021;1(1):137-9.
Lamirel C, Bruce BB, Newman N, Biousse V. Choroidal infarction in fulminant idiopathic intracranial hypertension. J Neuroophthalmol 2010;30(2):167-8.
Green GJ, Lessell S, Loewenstein JI. Ischemic optic neuropathy in chronic papilledema. Arch Ophthalmol 1980;98(3):502-4.
Molander LD, Hagen SM, Hansen NS, Korsbaek JJ, Grauslund J, Digre KB, et al. Patterns of retinal damage and visual long-term consequences in patients with idiopathic intracranial hypertension. Neurology 2025;105(10):e214335.
Schirmer CM, Hedges TR, 3rd. Mechanisms of visual loss in papilledema. Neurosurg Focus 2007;23(5):E5.
Bouffard MA. Fulminant idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 2020;20(4):8.
Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res 2009;28(1):34-62.
Archer EL, Pepin S. Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an association. J Clin Sleep Med 2013;9(6):613-8.
Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83(11):1287-90.
Abbott S, Chan F, Tahrani AA, Wong SH, Campbell FEJ, Parmar C, et al. Weight management interventions for adults with idiopathic intracranial hypertension: a systematic review and practice recommendations. Neurology 2023;101(21):e2138-50.
Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, et al. The effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2025;274:24-31.
Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, et al. Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study. Ophthalmology 2025;132(4):381-8.
Kim MK, Kim US. Analysis of fundus photography and fluorescein angiography in nonarteritic anterior ischemic optic neuropathy and optic neuritis. Korean J Ophthalmol 2016;30(4):289-94.